In conclusion, our study suggests that icariin has the potential to attenuate NASH, possibly by suppressing ferroptosis via the Nrf2-xCT/GPX4 pathway. This evidence concerns the gene SLC7A11 and metabolic dysfunction-associated steatohepatitis.